You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BET protein inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +3 more
  • (no location specified)
Jun 28, 2022

Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +7 more
  • Atlanta, Georgia
  • +2 more
Nov 3, 2022

Castrate Resistant Prostate Cancer, NUT Carcinoma Trial (EP31670)

Not yet recruiting
  • Castrate Resistant Prostate Cancer
  • NUT Carcinoma
  • (no location specified)
Aug 3, 2022

NUT Midline Carcinoma, Triple Negative Breast Cancer, NSCLC With Rearranged ALK Gene/Fusion Protein or KRAS Mutation Trial

Completed
Has Results
  • NUT Midline Carcinoma
  • +5 more
  • (no location specified)
Jan 7, 2021

Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET

Suspended
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • Boston, Massachusetts
    Dana-Farber - Harvard Cancer Center LAO
Sep 17, 2022

Metastatic Colorectal Adenocarcinoma, Refractory Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Trial (drug,

Not yet recruiting
  • Metastatic Colorectal Adenocarcinoma
  • +2 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +6 more
  • (no location specified)
Oct 25, 2023

Acute GVHD, Steroid Refractory GVHD Trial in Columbus (BRD4 Inhibitor PLX51107)

Recruiting
  • Acute Graft Versus Host Disease
  • Steroid Refractory Graft Versus Host Disease
  • BRD4 Inhibitor PLX51107
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 24, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • +8 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +7 more
  • (no location specified)
Jul 15, 2023

Lupus Nephritis Trial in Shanghai (68Ga-FAPI-04 PET)

Recruiting
  • Lupus Nephritis
  • 68Ga-FAPI-04 PET
  • Shanghai, China
    Ruijin Hospital
May 4, 2023

Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate

Not yet recruiting
  • Cancer of Cervix
  • Apoptosis
  • Immunohistochemistry
  • (no location specified)
Nov 17, 2023

Esophageal Achalasia Trial in Marseille, Montpellier, Nîmes (Protein pump inhibitor therapy systematically)

Recruiting
  • Esophageal Achalasia
  • Protein pump inhibitor therapy systematically
  • Marseille, France
  • +3 more
Jun 2, 2023

Breast Carcinoma, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Chicago

Not yet recruiting
  • Breast Carcinoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • Chicago, Illinois
    Northwestern University
Nov 14, 2023

Novel Antidiabetic Drug Combined With Angiotensin

Recruiting
  • Type 2 Diabetes
  • Antidiabetic Drugs
    • Beijing, Beijing, China
    • +1 more
    Jun 20, 2023

    Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

    Recruiting
    • Astrocytoma, Grades II, III and IV
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Healthy Adults Trial in Daytona Beach (Adagrasib, Eltrombopag + adagrasib)

    Recruiting
    • Healthy Adults
    • Daytona Beach, Florida
      Fortrea Clinical Research Unit Daytona Beach (Labcorp Clinical R
    Jun 29, 2023

    AML Including AML de Novo and AML Secondary to MDS, DLBCL Trial (Birabresib Dose 20 mg)

    Terminated
    Has Results
    • AML Including AML de Novo and AML Secondary to MDS
    • DLBCL
    • Birabresib Dose 20 mg
    • (no location specified)
    Aug 23, 2022

    Malignant Tumor, Positron Emission Tomography, Fibroblast Activation Protein Inhibitor Trial in Beijing (68Ga-TCR-FAPI PET/CT)

    Recruiting
    • Malignant Tumor
    • +2 more
    • 68Ga-TCR-FAPI PET/CT
    • Beijing, China
      Peking University Cancer Hospital
    Oct 19, 2023

    Fibroblast Activation Protein Inhibitor PET/CT Imaging in

    Recruiting
    • Gastrointestinal Cancer
    • Fibroblast activation protein inhibitor PET/CT imaging
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Jul 14, 2022

    Advanced Uveal Melanoma, Metastatic Uveal Melanoma, Unresectable Uveal Melanoma Trial (BRD4 Inhibitor PLX2853, Trametinib,

    Not yet recruiting
    • Advanced Uveal Melanoma
    • +2 more
    • BRD4 Inhibitor PLX2853
    • +4 more
    • (no location specified)
    Jan 9, 2023

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Boston, Galveston,

    Suspended
    • Advanced Malignant Solid Neoplasm
    • +4 more
    • Boston, Massachusetts
    • +2 more
    Oct 5, 2022

    Solid Tumor, Unspecified, Adult Trial in Meldola (68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission

    Recruiting
    • Solid Tumor, Unspecified, Adult
    • 68 Gallium -Fibroblast Activating Protein Inhibitor -46 Positron emission tomography / Computerized tomography
    • Meldola, Forlì Cesena, Italy
      IRCCS Istituto ROmagnolo per lo Studio dei Tumori "Dino Amadori"
    Nov 15, 2023

    Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in

    Recruiting
    • Metastatic Malignant Solid Neoplasm
    • +3 more
    • BET Bromodomain Inhibitor ZEN-3694
    • +2 more
    • Bethesda, Maryland
    • +4 more
    Aug 16, 2022

    Cancer, Peritoneal Carcinomatosis Trial in Brussels (FAPI PET/CT)

    Recruiting
    • Cancer
    • Peritoneal Carcinomatosis
    • FAPI PET/CT
    • Brussels, Belgium
      Institut Jules Bordet
    Sep 25, 2023

    Healthy Volunteers Trial in San Francisco (Rosuvastatin, Rosuvastatin (Inhibitor arm), Eltrombopag)

    Recruiting
    • Healthy Volunteers
    • San Francisco, California
      Ucsf Ctsi Crc
    Nov 29, 2022